Table 3 Comparison of main outcome measures by study arm, Boromo Health District, Burkina Faso (2004–2006)
| Â | Study arms | Comparisons | ||||
|---|---|---|---|---|---|---|
| Â | Intervention | Â | Â | Â | Â | |
Characteristic | A | B | Control | A vs. Control | B vs. Control | A vs. B |
| Â | Â | % (n/N) | Â | Â | OR (95%CI) | Â |
Antenatal care | Â | Â | Â | Â | Â | Â |
≥ 3 ANC visits | 62.3 (463/743) | 42.3 (339/801) | 45.8 (341/744) | 1.95 (0.86–4.45) | 0.87 (0.36–2.10) | 2.25 (0.86–5.92) |
1st ANC visit in third trimester †| 18.7 (127/679) | 28.5 (199/699) | 30.8 (205/666) | 0.52 (0.26–1.03) | 0.90 (0.47–1.70) | 0.58** (0.44–0.76) |
≥ 2 doses IPT-SP | 69.9 (519/743) | 48.6 (389/801) |  |  |  | 2.45* (1.25–4.82) |
Home visit at 32 weeks | Â | Â | Â | Â | Â | Â |
Anaemia (PCV < 33) | 49.4 (288/583) | 48.7 (285/585) | 56.4 (299/530) | 0.75 (0.37–1.54) | 0.73 (0.36–1.50) | 1.03 (0.68–1.56) |
Moderate/severe anaemia (PCV < 30) | 23.8 (139/583) | 27.7 (162/585) | 30.2 (160/530) | 0.72 (0.39–1.34) | 0.89 (0.45–1.73) | 0.82 (0.62–1.08) |
Peripheral parasitaemia | 20.3 (121/597) | 19.4 (120/618) | 29.9 (167/558) | 0.60* (0.39–0.91) | 0.56** (0.40–0.80) | 1.05 (0.67–1.67) |
Delivery | Â | Â | Â | Â | Â | Â |
Anaemia (PCV < 33) ‡ | 31.1 (137/440) | 32.8 (131/399) | 40.2 (150/373) | 0.67 (0.38–1.18) | 0.73 (0.39–1.36) | 0.92 (0.51–1.69) |
Moderate/severe anaemia (PCV < 30) ‡ | 16.8 (74/440) | 16.8 (67/399) | 19.8 (74/373) | 0.82 (0.46–1.46) | 0.82 (0.46–1.46) | 1.00 (0.58–1.72) |
Peripheral parasitaemia‡ | 17.4 (87/499) | 20.1 (95/472) | 33.3 (144/432) | 0.42*** (0.30–0.60) | 0.50** (0.37–0.69) | 0.84 (0.60–1.18) |
Placental parasitaemia | 18.1 (89/491) | 20.5 (90/440) | 30.3 (131/432) | 0.51** (0.37–0.70) | 0.59* (0.44–0.78) | 0.86 (0.58–1.29) |
Low birth weight (< 2500 grams) § | 16.2 (95/585) | 18.6 (128/687) | 22.3 (132/593) | 0.68 (0.42–1.08) | 0.80 (0.46–1.39) | 0.85 (0.61–1.17) |
Miscarriage/stillbirths || | 5.5 (41/742) | 4.1 (33/801) | 4.9 (36/742) | 1.15 (0.89–1.48) | 0.84 (0.55–1.28) | 1.36 (0.88–2.12) |